Why is warfarin underutilized in patients with atrial fibrillation?
Flaker
Greg C
GC
University of Missouri, Columbia, One Hospital Drive, DC034.00, Room MC314, Columbia, MO 65212, USA. flakerg@health.missouri.edu
Schutz
John
J
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D004363:Drug Utilization; D006801:Humans; D010818:Practice Patterns, Physicians'; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin